Patient Pathfinder: Clinical Trials
Clinical Trials for Hypertrophic Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 27 active Hypertrophic Cardiomyopathy trials
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional
Coronary Artery Disease in Patients With Friedreich’s Ataxia
Study Type: Interventional
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 3
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
Study Type: Observational
CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM
Study Type: Interventional Phase 3
A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 2
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
Study Type: Interventional Phase 3
Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Study Type: Interventional Phase 1
There are 27 active Hypertrophic Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now